{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:37:18Z","timestamp":1783449438488,"version":"3.55.0"},"reference-count":88,"publisher":"Bentham Science Publishers Ltd.","issue":"6","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Epigenetic mechanisms alter gene expression and regulate vital cellular\nprocesses that contribute to the onset and progression of major dental diseases. Their reversible character\nmay prove beneficial for therapeutic targeting. This review aims to provide an update on the\nmain epigenetic changes that contribute to the pathogenesis of Oral Squamous Cell Carcinoma\n(OSCC), pulpitis and periodontitis as well as dental caries and congenital orofacial malformations, in\nan effort to identify potential therapeutic targets.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>We undertook a structured search of bibliographic databases (PubMed and MEDLINE) for\npeer-reviewed epigenetic research studies focused on oral diseases in the last ten years. A qualitative\ncontent analysis was performed in screened papers and a critical discussion of main findings is provided.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>Several epigenetic modifications have been associated with OSCC pathogenesis, including\npromoter methylation of genes involved in DNA repair, cell cycle regulation and proliferation leading\nto malignant transformation. Additionally, epigenetic inactivation of tumor suppressor genes, overexpression\nof histone chaperones and several microRNAs are implicated in OSCC aggressiveness.\nChanges in the methylation patterns of IFN-\u03b3 and trimethylation of histone \u03973\u039a27 have been detected\nin pulpitis, along with an aberrant expression of several microRNAs, mainly affecting cytokine production.\nChronic periodontal disease has been associated with modifications in the methylation patterns\nof Toll-Like Receptor 2, Prostaglandin synthase 2, E-cadherin and some inflammatory cytokines,\nalong with the overexpression of miR-146a and miR155. Furthermore, DNA methylation was\nfound to regulate amelogenesis and has been implicated in the pathogenesis of dental caries as well as\nin several congenital orofacial malformations.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Strong evidence indicates that epigenetic changes participate in the pathogenesis of oral\ndiseases and epigenetic targeting may be considered as a complementary therapeutic scheme to the\ncurrent management of oral health.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867327666200114114802","type":"journal-article","created":{"date-parts":[[2020,1,14]],"date-time":"2020-01-14T13:14:14Z","timestamp":1579007654000},"page":"1091-1103","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Impact of Epigenetic Alterations in the Development of Oral Diseases"],"prefix":"10.2174","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9267-1703","authenticated-orcid":true,"given":"Rodopi","family":"Emfietzoglou","sequence":"first","affiliation":[{"name":"School of Dentistry, National and Kapodistrian University of Athens, 2 Thivon Str, Goudi, 115 27 Athens,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2020-302X","authenticated-orcid":true,"given":"Evangelos","family":"Pachymanolis","sequence":"additional","affiliation":[{"name":"School of Dentistry, National and Kapodistrian University of Athens, 2 Thivon Str, Goudi, 115 27 Athens,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-0618","authenticated-orcid":true,"given":"Christina","family":"Piperi","sequence":"additional","affiliation":[{"name":"Department of Biological Chemistry, School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias street, 115 27 Athens,Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5395\/rde.2015.40.1.14","volume":"40","author":"Seo J.Y.","year":"2015","unstructured":"Seo J.Y.; Park Y.J.; Yi Y.A.; Hwang J.Y.; Lee I.B.; Cho B.H.; Son H.H.; Seo D.G.; Epigenetics: general characteristics and implications for oral health. Restor Dent Endod 2015,40(1),14-22","journal-title":"Restor Dent Endod"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.2174\/0929867324666170921101947","volume":"26","author":"Li Y.","year":"2019","unstructured":"Li Y.; Li Z.; Zhu W.G.; Molecular mechanisms of epigenetic regulators as activatable targets in cancer theranostics. Curr Med Chem 2019,26(8),1328-1350","journal-title":"Curr Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1389450118666170125144557","volume":"19","author":"Manikandan P.","year":"2018","unstructured":"Manikandan P.; Nagini S.; Cytochrome P450 structure, function and clinical significance: a review. Curr Drug Targets 2018,19(1),38-54","journal-title":"Curr Drug Targets"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1111\/adj.12155","volume":"59","author":"Williams S.D.","year":"2014","unstructured":"Williams S.D.; Hughes T.E.; Adler C.J.; Brook A.H.; Townsend G.C.; Epigenetics: a new frontier in dentistry. Aust Dent J 2014,59(1)(Suppl. 1),23-33","journal-title":"Aust Dent J"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4103\/0973-029X.180967","volume":"20","author":"Singh N.N.","year":"2016","unstructured":"Singh N.N.; Peer A.; Nair S.; Chaturvedi R.K.; Epigenetics: a possible answer to the undeciphered etiopathogenesis and behavior of oral lesions. J Oral Maxillofac Pathol 2016,20(1),122-128","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.2174\/1389450117666161228160455","volume":"18","author":"Sun C.","year":"2017","unstructured":"Sun C.; Duan P.; Luan C.; CEBP epigenetic dysregulation as a drug target for the treatment of hematologic and gynecologic malignancies. Curr Drug Targets 2017,18(10),1142-1151","journal-title":"Curr Drug Targets"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.2174\/1389450118666170911114342","volume":"19","author":"Bhargava A.","year":"2018","unstructured":"Bhargava A.; Bunkar N.; Aglawe A.; Pandey K.C.; Tiwari R.; Chaudhury K.; Goryacheva I.Y.; Mishra P.K.; Epigenetic biomarkers for risk assessment of particulate matter associated lung cancer. Curr Drug Targets 2018,19(10),1127-1147","journal-title":"Curr Drug Targets"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.2174\/1389450118666171122141821","volume":"19","author":"Raghuwanshi S.","year":"2018","unstructured":"Raghuwanshi S.; Dahariya S.; Kandi R.; Gutti U.; Undi R.B.; Sharma D.S.; Sahu I.; Kovuru N.; Yarla N.S.; Saladi R.G.V.; Gutti R.K.; Epigenetic mechanisms: role in hematopoietic stem cell lineage commitment and differentiation. Curr Drug Targets 2018,19(14),1683-1695","journal-title":"Curr Drug Targets"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cbpa.2019.01.024","volume":"51","author":"Yao Q.","year":"2019","unstructured":"Yao Q.; Chen Y.; Zhou X.; The roles of microRNAs in epigenetic regulation. Curr Opin Chem Biol 2019,51,11-17","journal-title":"Curr Opin Chem Biol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"397","DOI":"10.17219\/acem\/76060]","volume":"28","author":"Josko-Ochojska J.","year":"2019","unstructured":"Josko-Ochojska J.; Rygiel K.; Postek-Stefanska L.; Diseases of the oral cavity in light of the newest epigenetic research: possible implications for stomatology. Adv Clin Exp Med 2019,28(3),397-406","journal-title":"Adv Clin Exp Med"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1002\/cncr.20772","volume":"103","author":"Almadori G.","year":"2005","unstructured":"Almadori G.; Bussu F.; Galli J.; Cadoni G.; Zappacosta B.; Persichilli S.; Minucci A.; Giardina B.; Maurizi M.; Serum levels of folate, homocysteine, and vitamin B12 in head and neck squamous cell carcinoma and in laryngeal leukoplakia. Cancer 2005,103(2),284-292","journal-title":"Cancer"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1093\/hmg\/ddr593","volume":"21","author":"Bebek G.","year":"2012","unstructured":"Bebek G.; Bennett K.L.; Funchain P.; Campbell R.; Seth R.; Scharpf J.; Burkey B.; Eng C.; Microbiomic subprofiles and MDR1 promoter methylation in head and neck squamous cell carcinoma. Hum Mol Genet 2012,21(7),1557-1565","journal-title":"Hum Mol Genet"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1590\/S0100-879X2010007500034","volume":"43","author":"Galbiatti A.L.","year":"2010","unstructured":"Galbiatti A.L.; Ruiz M.T.; Biselli-Chicote P.M.; Raposo L.S.; Maniglia J.V.; Pavarino-Bertelli E.C.; Goloni-Bertollo E.M.; 5-Methyltetrahydrofolate-homocysteine methyltransferase gene polymorphism (MTR) and risk of head and neck cancer. Braz J Med Biol Res 2010,43(5),445-450","journal-title":"Braz J Med Biol Res"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.3390\/ijms13022331","volume":"13","author":"Mascolo M.","year":"2012","unstructured":"Mascolo M.; Siano M.; Ilardi G.; Russo D.; Merolla F.; De Rosa G.; Staibano S.; Epigenetic disregulation in oral cancer. Int J Mol Sci 2012,13(2),2331-2353","journal-title":"Int J Mol Sci"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/j.1601-0825.2011.01789.x","volume":"17","author":"Lingen M.W.","year":"2011","unstructured":"Lingen M.W.; Pinto A.; Mendes R.A.; Franchini R.; Czerninski R.; Tilakaratne W.M.; Partridge M.; Peterson D.E.; Woo S.B.; Genetics\/epigenetics of oral premalignancy: current status and future research. Oral Dis 2011,17(Suppl. 1),7-22","journal-title":"Oral Dis"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1186\/s12885-018-4806-7","volume":"18","author":"Zhong L.","year":"2018","unstructured":"Zhong L.; Liu Y.; Wang K.; He Z.; Gong Z.; Zhao Z.; Yang Y.; Gao X.; Li F.; Wu H.; Zhang S.; Chen L.; Biomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinoma. BMC Cancer 2018,18(1),911","journal-title":"BMC Cancer"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/bjc.2012.568","volume":"108","author":"Jithesh P.V.","year":"2013","unstructured":"Jithesh P.V.; Risk J.M.; Schache A.G.; Dhanda J.; Lane B.; Liloglou T.; Shaw R.J.; The epigenetic landscape of oral squamous cell carcinoma. Br J Cancer 2013,108(2),370-379","journal-title":"Br J Cancer"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1038\/bjc.2013.667","volume":"109","author":"Bravi F.","year":"2013","unstructured":"Bravi F.; Bosetti C.; Filomeno M.; Levi F.; Garavello W.; Galimberti S.; Negri E.; La Vecchia C.; Foods, nutrients and the risk of oral and pharyngeal cancer. Br J Cancer 2013,109(11),2904-2910","journal-title":"Br J Cancer"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.bbrc.2017.10.035","volume":"494","author":"de \u00c1vila M.B.","year":"2017","unstructured":"de \u00c1vila M.B.; Xavier M.M.; Pintro V.O.; de Azevedo W.F.; Jr. Supervised machine learning techniques to predict binding affinity. A study for cyclin-dependent kinase 2. Biochem Biophys Res Commun 2017,494(1-2),305-310","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bpc.2018.01.004","volume":"235","author":"Levin N.M.B.","year":"2018","unstructured":"Levin N.M.B.; Pintro V.O.; Bitencourt-Ferreira G.; de Mattos B.B.; de Castro Silv\u00e9rio A.; de Azevedo W.F.; Jr. Development of CDK-targeted scoring functions for prediction of binding affinity. Biophys Chem 2018,235,1-8","journal-title":"Biophys Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"716","DOI":"10.2174\/1389450120666181204165344","volume":"20","author":"Volkart P.A.","year":"2019","unstructured":"Volkart P.A.; Bitencourt-Ferreira G.; Souto A.A.; de Azevedo W.F.; Cyclin-dependent kinase 2 in cellular senescence and cancer. A structural and functional review. Curr Drug Targets 2019,20(7),716-726","journal-title":"Curr Drug Targets"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1177\/0022034518816947","volume":"98","author":"Bais M.V.","year":"2019","unstructured":"Bais M.V.; Impact of epigenetic regulation on head and neck squamous cell carcinoma. J Dent Res 2019,98(3),268-276","journal-title":"J Dent Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"8902","DOI":"10.1038\/sj.onc.1207050","volume":"22","author":"Coombes M.M.","year":"2003","unstructured":"Coombes M.M.; Briggs K.L.; Bone J.R.; Clayman G.L.; El-Naggar A.K.; Dent S.Y.; Resetting the histone code at CDKN2A in HNSCC by inhibition of DNA methylation. Oncogene 2003,22(55),8902-8911","journal-title":"Oncogene"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"2","DOI":"10.2174\/138945011701151217100907","volume":"17","author":"de Azevedo W.F.","year":"2016","unstructured":"de Azevedo W.F.; Jr. Opinion paper: targeting multiple cyclin-dependent kinases (CDKs): A new strategy for molecular docking studies. Curr Drug Targets 2016,17(1),2","journal-title":"Curr Drug Targets"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.2174\/1389450118666161116130155","volume":"18","author":"Levin N.M.B.","year":"2017","unstructured":"Levin N.M.B.; Pintro V.O.; de Avila M.B.; de Mattos B.B.; de Azevedo W.F.; Jr. Understanding the structural basis for inhibition of cyclin-dependent kinases. New pieces in the molecular puzzle. Curr Drug Targets 2017,18(9),1104-1111","journal-title":"Curr Drug Targets"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13402-016-0293-5","volume":"39","author":"Ribeiro I.P.","year":"2016","unstructured":"Ribeiro I.P.; Caramelo F.; Marques F.; Domingues A.; Mesquita M.; Barroso L.; Prazeres H.; Juli\u00e3o M.J.; Baptista I.P.; Ferreira A.; Melo J.B.; Carreira I.M.; WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report. Cell Oncol (Dordr) 2016,39(6),573-582","journal-title":"Cell Oncol (Dordr)"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/j.1349-7006.2008.00769.x","volume":"99","author":"Imai T.","year":"2008","unstructured":"Imai T.; Toyota M.; Suzuki H.; Akino K.; Ogi K.; Sogabe Y.; Kashima L.; Maruyama R.; Nojima M.; Mita H.; Sasaki Y.; Itoh F.; Imai K.; Shinomura Y.; Hiratsuka H.; Tokino T.; Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma. Cancer Sci 2008,99(5),958-966","journal-title":"Cancer Sci"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.1002\/cncr.28356","volume":"119","author":"Chen Y.W.","year":"2013","unstructured":"Chen Y.W.; Kao S.Y.; Wang H.J.; Yang M.H.; Histone modification patterns correlate with patient outcome in oral squamous cell carcinoma. Cancer 2013,119(24),4259-4267","journal-title":"Cancer"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1868-7083-3-6","volume":"3","author":"Rigi-Ladiz M.A.","year":"2011","unstructured":"Rigi-Ladiz M.A.; Kordi-Tamandani D.M.; Torkamanzehi A.; Analysis of hypermethylation and expression profiles of APC and ATM genes in patients with oral squamous cell carcinoma. Clin Epigen 2011,3,6","journal-title":"Clin Epigen"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"597","DOI":"10.3892\/ijmm.15.4.597","volume":"15","author":"Uesugi H.","year":"2005","unstructured":"Uesugi H.; Uzawa K.; Kawasaki K.; Shimada K.; Moriya T.; Tada A.; Shiiba M.; Tanzawa H.; Status of reduced expression and hypermethylation of the APC tumor suppressor gene in human oral squamous cell carcinoma. Int J Mol Med 2005,15(4),597-602","journal-title":"Int J Mol Med"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.3892\/ijo.32.6.1253","volume":"32","author":"Sogabe Y.","year":"2008","unstructured":"Sogabe Y.; Suzuki H.; Toyota M.; Ogi K.; Imai T.; Nojima M.; Sasaki Y.; Hiratsuka H.; Tokino T.; Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma. Int J Oncol 2008,32(6),1253-1261","journal-title":"Int J Oncol"},{"key":"ref=32","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000009971","volume":"97","author":"Wen G.","year":"2018","unstructured":"Wen G.; Wang H.; Zhong Z.; Associations of RASSF1A, RAR\u03b2, and CDH1 promoter hypermethylation with oral cancer risk: A PRISMA-compliant meta-analysis. Medicine (Baltimore) 2018,97(11)","journal-title":"Medicine (Baltimore)"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/j.oraloncology.2014.08.015","volume":"50","author":"Langevin S.M.","year":"2014","unstructured":"Langevin S.M.; Butler R.A.; Eliot M.; Pawlita M.; Maccani J.Z.; McClean M.D.; Kelsey K.T.; Novel DNA methylation targets in oral rinse samples predict survival of patients with oral squamous cell carcinoma. Oral Oncol 2014,50(11),1072-1080","journal-title":"Oral Oncol"},{"key":"ref=34","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030670","volume":"19","author":"Irimie A.I.","year":"2018","unstructured":"Irimie A.I.; Ciocan C.; Gulei D.; Mehterov N.; Atanasov A.G.; Dudea D.; Berindan-Neagoe I.; Current insights into oral cancer epigenetics. Int J Mol Sci 2018,19(3)","journal-title":"Int J Mol Sci"},{"key":"ref=35","first-page":"1429","volume":"19","author":"Kurasawa Y.","year":"2008","unstructured":"Kurasawa Y.; Shiiba M.; Nakamura M.; Fushimi K.; Ishigami T.; Bukawa H.; Yokoe H.; Uzawa K.; Tanzawa H.; PTEN expression and methylation status in oral squamous cell carcinoma. Oncol Rep 2008,19(6),1429-1434","journal-title":"Oncol Rep"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"7625","DOI":"10.1007\/s13277-015-4648-8","volume":"37","author":"Sushma P.S.","year":"2016","unstructured":"Sushma P.S.; Jamil K.; Kumar P.U.; Satyanarayana U.; Ramakrishna M.; Triveni B.; PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population. Tumour Biol 2016,37(6),7625-7632","journal-title":"Tumour Biol"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2174\/1389450120666190402120701","volume":"20","author":"Zanjirband M.","year":"2019","unstructured":"Zanjirband M.; Rahgozar S.; Targeting p53-MDM2 interaction using small molecule inhibitors and the challenges needed to be addressed. Curr Drug Targets 2019,20(11),1091-1111","journal-title":"Curr Drug Targets"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.2174\/1389450119666180226124349","volume":"19","author":"Perdas E.","year":"2018","unstructured":"Perdas E.; Stawski R.; Nowak D.; Zubrzycka M.; Potential of liquid biopsy in papillary thyroid carcinoma in context of miRNA, BRAF and p53 mutation. Curr Drug Targets 2018,19(14),1721-1729","journal-title":"Curr Drug Targets"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.2174\/1389450119666180115165447","volume":"19","author":"Valente J.F.A.","year":"2018","unstructured":"Valente J.F.A.; Queiroz J.A.; Sousa F.; p53 as the focus of gene therapy: past, present and future. Curr Drug Targets 2018,19(15),1801-1817","journal-title":"Curr Drug Targets"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.3892\/br.2018.1136]","volume":"9","author":"Russo D.","year":"2018","unstructured":"Russo D.; Merolla F.; Varricchio S.; Salzano G.; Zarrilli G.; Mascolo M.; Strazzullo V.; Di Crescenzo R.M.; Celetti A.; Ilardi G.; Epigenetics of oral and oropharyngeal cancers. Biomed Rep 2018,9(4),275-283","journal-title":"Biomed Rep"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1177\/0022034515621728","volume":"95","author":"Cheng J.C.","year":"2016","unstructured":"Cheng J.C.; Chiang M.T.; Lee C.H.; Liu S.Y.; Chiu K.C.; Chou Y.T.; Huang R.Y.; Huang S.M.; Shieh Y.S.; \u03b3-Synuclein expression is a malignant index in oral squamous cell carcinoma. J Dent Res 2016,95(4),439-445","journal-title":"J Dent Res"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3892\/ijo.29.1.117","volume":"29","author":"Sakuma T.","year":"2006","unstructured":"Sakuma T.; Uzawa K.; Onda T.; Shiiba M.; Yokoe H.; Shibahara T.; Tanzawa H.; Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma. Int J Oncol 2006,29(1),117-124","journal-title":"Int J Oncol"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"4818","DOI":"10.1093\/hmg\/ddp446","volume":"18","author":"Cervigne N.K.","year":"2009","unstructured":"Cervigne N.K.; Reis P.P.; Machado J.; Sadikovic B.; Bradley G.; Galloni N.N.; Pintilie M.; Jurisica I.; Perez-Ordonez B.; Gilbert R.; Gullane P.; Irish J.; Kamel-Reid S.; Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet 2009,18(24),4818-4829","journal-title":"Hum Mol Genet"},{"key":"ref=44","doi-asserted-by":"publisher","DOI":"10.3390\/cancers11050610","volume":"11","author":"Falzone L.","year":"2019","unstructured":"Falzone L.; Lupo G.; La Rosa G.R.M.; Crimi S.; Anfuso C.D.; Salemi R.; Rapisarda E.; Libra M.; Candido S.; Identification of novel micrornas and their diagnostic and prognostic significance in oral cancer. Cancers (Basel) 2019,11(5)","journal-title":"Cancers (Basel)"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.molcel.2010.05.027","volume":"38","author":"Hu W.","year":"2010","unstructured":"Hu W.; Chan C.S.; Wu R.; Zhang C.; Sun Y.; Song J.S.; Tang L.H.; Levine A.J.; Feng Z.; Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell 2010,38(5),689-699","journal-title":"Mol Cell"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1158\/0008-5472.CAN-07-5194","volume":"68","author":"Kozaki K.","year":"2008","unstructured":"Kozaki K.; Imoto I.; Mogi S.; Omura K.; Inazawa J.; Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 2008,68(7),2094-2105","journal-title":"Cancer Res"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.coms.2018.06.007","volume":"30","author":"Lubek J.E.","year":"2018","unstructured":"Lubek J.E.; Head and neck cancer research and support foundations. Oral Maxillofac Surg Clin North Am 2018,30(4),459-469","journal-title":"Oral Maxillofac Surg Clin North Am"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/21505594.2014.999570","volume":"6","author":"H\u00fcbbers C.U.","year":"2015","unstructured":"H\u00fcbbers C.U.; Akg\u00fcl B.; HPV and cancer of the oral cavity. Virulence 2015,6(3),244-248","journal-title":"Virulence"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1601-0825.2011.01792.x","volume":"17","author":"Syrj\u00e4nen S.","year":"2011","unstructured":"Syrj\u00e4nen S.; Lodi G.; von B\u00fcltzingsl\u00f6wen I.; Aliko A.; Arduino P.; Campisi G.; Challacombe S.; Ficarra G.; Flaitz C.; Zhou H.M.; Maeda H.; Miller C.; Jontell M.; Human papillomaviruses in oral carcinoma and oral potentially malignant disorders: a systematic review. Oral Dis 2011,17(1)(Suppl. 1),58-72","journal-title":"Oral Dis"},{"key":"ref=50","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2019.113676","author":"Bonelli M.","year":"2019","unstructured":"Bonelli M.; La Monica S.; Fumarola C.; Alfieri R.; Multiple effects of CDK4\/6 inhibition in cancer: from cell cycle arrest to immunomodulation. Biochem Pharmacol 2019","journal-title":"Biochem Pharmacol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"666","DOI":"10.3389\/fonc.2019.00666","volume":"9","author":"McCartney A.","year":"2019","unstructured":"McCartney A.; Migliaccio I.; Bonechi M.; Biagioni C.; Romagnoli D.; De Luca F.; Galardi F.; Risi E.; De Santo I.; Benelli M.; Malorni L.; Di Leo A.; Mechanisms of resistance to CDK4\/6 inhibitors: potential implications and biomarkers for clinical practice. Front Oncol 2019,9,666","journal-title":"Front Oncol"},{"key":"ref=52","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmcl.2019.126637","volume":"29","author":"S\u00e1nchez-Mart\u00ednez C.","year":"2019","unstructured":"S\u00e1nchez-Mart\u00ednez C.; Lallena M.J.; Sanfeliciano S.G.; de Dios A.; Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015-2019). Bioorg Med Chem Lett 2019,29(20)","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.pop.2013.10.011","volume":"41","author":"Silk H.","year":"2014","unstructured":"Silk H.; Diseases of the mouth. Prim Care 2014,41(1),75-90","journal-title":"Prim Care"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/gene.2016.14","volume":"17","author":"Galicia J.C.","year":"2016","unstructured":"Galicia J.C.; Henson B.R.; Parker J.S.; Khan A.A.; Gene expression profile of pulpitis. Genes Immun 2016,17(4),239-243","journal-title":"Genes Immun"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.4103\/jispcd.JISPCD_290_17","volume":"7","author":"Irani S.","year":"2017","unstructured":"Irani S.; Orofacial bacterial infectious diseases: an update. J Int Soc Prev Community Dent 2017,7(Suppl. 2),S61-S67","journal-title":"J Int Soc Prev Community Dent"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.joen.2011.12.014","volume":"38","author":"Duncan H.F.","year":"2012","unstructured":"Duncan H.F.; Smith A.J.; Fleming G.J.; Cooper P.R.; Histone deacetylase inhibitors induced differentiation and accelerated mineralization of pulp-derived cells. J Endod 2012,38(3),339-345","journal-title":"J Endod"},{"key":"ref=57","first-page":"303","volume":"25","author":"Kokkas A.","year":"2011","unstructured":"Kokkas A.; Goulas A.; Stavrianos C.; Anogianakis G.; The role of cytokines in pulp inflammation. J Biol Regul Homeost Agents 2011,25(3),303-311","journal-title":"J Biol Regul Homeost Agents"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/odi.12464","volume":"23","author":"Hui T.","year":"2017","unstructured":"Hui T.; Wang C.; Chen D.; Zheng L.; Huang D.; Ye L.; Epigenetic regulation in dental pulp inflammation. Oral Dis 2017,23(1),22-28","journal-title":"Oral Dis"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1574888X12666170718161740","volume":"13","author":"Luo Y.","year":"2018","unstructured":"Luo Y.; Peng X.; Duan D.; Liu C.; Xu X.; Zhou X.; Epigenetic regulations in the pathogenesis of periodontitis. Curr Stem Cell Res Ther 2018,13(2),144-150","journal-title":"Curr Stem Cell Res Ther"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/j.humimm.2013.04.037","volume":"74","author":"de Faria Amormino S.A.","year":"2013","unstructured":"de Faria Amormino S.A.; Ar\u00e3o T.C.; Saraiva A.M.; Gomez R.S.; Dutra W.O.; da Costa J.E.; de F\u00e1tima Correia Silva J.; Moreira P.R.; Hypermethylation and low transcription of TLR2 gene in chronic periodontitis. Hum Immunol 2013,74(9),1231-1236","journal-title":"Hum Immunol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/idh.12030","volume":"12","author":"Lod S.","year":"2014","unstructured":"Lod S.; Johansson T.; Abrahamsson K.H.; Larsson L.; The influence of epigenetics in relation to oral health. Int J Dent Hyg 2014,12(1),48-54","journal-title":"Int J Dent Hyg"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/1479-5876-8-110","volume":"8","author":"Loo W.T.","year":"2010","unstructured":"Loo W.T.; Jin L.; Cheung M.N.; Wang M.; Chow L.W.; Epigenetic change in E-cadherin and COX-2 to predict chronic periodontitis. J Transl Med 2010,8,110","journal-title":"J Transl Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/0972-124X.145784","volume":"19","author":"Lavu V.","year":"2015","unstructured":"Lavu V.; Venkatesan V.; Rao S.R.; The epigenetic paradigm in periodontitis pathogenesis. J Indian Soc Periodontol 2015,19(2),142-149","journal-title":"J Indian Soc Periodontol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/0022034509356512","volume":"89","author":"Zhang S.","year":"2010","unstructured":"Zhang S.; Barros S.P.; Niculescu M.D.; Moretti A.J.; Preisser J.S.; Offenbacher S.; Alteration of PTGS2 promoter methylation in chronic periodontitis. J Dent Res 2010,89(2),133-137","journal-title":"J Dent Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.humimm.2015.10.007","volume":"77","author":"Schulz S.","year":"2016","unstructured":"Schulz S.; Immel U.D.; Just L.; Schaller H.G.; Gl\u00e4ser C.; Reichert S.; Epigenetic characteristics in inflammatory candidate genes in aggressive periodontitis. Hum Immunol 2016,77(1),71-75","journal-title":"Hum Immunol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s40496-017-0156-9","volume":"4","author":"Larsson L.","year":"2017","unstructured":"Larsson L.; Current concepts of epigenetics and its role in periodontitis. Curr Oral Health Rep 2017,4(4),286-293","journal-title":"Curr Oral Health Rep"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5051\/jpis.2013.43.3.111","volume":"43","author":"Lindroth A.M.","year":"2013","unstructured":"Lindroth A.M.; Park Y.J.; Epigenetic biomarkers: a step forward for understanding periodontitis. J Periodontal Implant Sci 2013,43(3),111-120","journal-title":"J Periodontal Implant Sci"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"252","DOI":"10.4103\/jomfp.JOMFP_150_17","volume":"21","author":"Hema K.N.","year":"2017","unstructured":"Hema K.N.; Smitha T.; Sheethal H.S.; Mirnalini S.A.; Epigenetics in oral squamous cell carcinoma. J Oral Maxillofac Pathol 2017,21(2),252-259","journal-title":"J Oral Maxillofac Pathol"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/jbmr.1491","volume":"27","author":"Delgado-Calle J.","year":"2012","unstructured":"Delgado-Calle J.; Sa\u00f1udo C.; Bolado A.; Fern\u00e1ndez A.F.; Arozamena J.; Pascual-Carra M.A.; Rodriguez-Rey J.C.; Fraga M.F.; Bonewald L.; Riancho J.A.; DNA methylation contributes to the regulation of sclerostin expression in human osteocytes. J Bone Miner Res 2012,27(4),926-937","journal-title":"J Bone Miner Res"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00418-015-1353-z","volume":"144","author":"Yoshioka H.","year":"2015","unstructured":"Yoshioka H.; Minamizaki T.; Yoshiko Y.; The dynamics of DNA methylation and hydroxymethylation during amelogenesis. Histochem Cell Biol 2015,144(5),471-478","journal-title":"Histochem Cell Biol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s12903-015-0143-2","volume":"15","author":"Fernando S.","year":"2015","unstructured":"Fernando S.; Speicher D.J.; Bakr M.M.; Benton M.C.; Lea R.A.; Scuffham P.A.; Mihala G.; Johnson N.W.; Protocol for assessing maternal, environmental and epigenetic risk factors for dental caries in children. BMC Oral Health 2015,15,167","journal-title":"BMC Oral Health"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/bdra.20788","volume":"91","author":"Plamondon J.A.","year":"2011","unstructured":"Plamondon J.A.; Harris M.J.; Mager D.L.; Gagnier L.; Juriloff D.M.; The clf2 gene has an epigenetic role in the multifactorial etiology of cleft lip and palate in the A\/WySn mouse strain. Birth Defects Res A Clin Mol Teratol 2011,91(8),716-727","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.reprotox.2009.02.014","volume":"28","author":"Ornoy A.","year":"2009","unstructured":"Ornoy A.; Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Reprod Toxicol 2009,28(1),1-10","journal-title":"Reprod Toxicol"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.archoralbio.2014.03.005","volume":"59","author":"Desh H.","year":"2014","unstructured":"Desh H.; Gray S.L.; Horton M.J.; Raoul G.; Rowlerson A.M.; Ferri J.; Vieira A.R.; Sciote J.J.; Molecular motor MYO1C, acetyltransferase KAT6B and osteogenetic transcription factor RUNX2 expression in human masseter muscle contributes to development of malocclusion. Arch Oral Biol 2014,59(6),601-607","journal-title":"Arch Oral Biol"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2016.02.004","volume":"374","author":"Wang Y.","year":"2016","unstructured":"Wang Y.; Zhu Y.; Wang Q.; Hu H.; Li Z.; Wang D.; Zhang W.; Qi B.; Ye J.; Wu H.; Jiang H.; Liu L.; Yang J.; Cheng J.; The histone demethylase LSD1 is a novel oncogene and therapeutic target in oral cancer. Cancer Lett 2016,374(1),12-21","journal-title":"Cancer Lett"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.2217\/fon.12.138","volume":"8","author":"Gasche J.A.","year":"2012","unstructured":"Gasche J.A.; Goel A.; Epigenetic mechanisms in oral carcinogenesis. Future Oncol 2012,8(11),1407-1425","journal-title":"Future Oncol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3892\/ijo.28.5.1233","volume":"28","author":"Sato T.","year":"2006","unstructured":"Sato T.; Suzuki M.; Sato Y.; Echigo S.; Rikiishi H.; Sequence-dependent interaction between cisplatin and histone deacetylase inhibitors in human oral squamous cell carcinoma cells. Int J Oncol 2006,28(5),1233-1241","journal-title":"Int J Oncol"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.oraloncology.2008.11.009","volume":"45","author":"Nagumo T.","year":"2009","unstructured":"Nagumo T.; Takaoka S.; Yoshiba S.; Ohashi M.; Shirota T.; Hatori M.; Isobe T.; Tachikawa T.; Shintani S.; Antitumor activity of suberoylanilide hydroxamic acid against human oral squamous cell carcinoma cell lines in vitro and in vivo. Oral Oncol 2009,45(9),766-770","journal-title":"Oral Oncol"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s13402-015-0255-3","volume":"39","author":"Jang B.","year":"2016","unstructured":"Jang B.; Shin J.A.; Kim Y.S.; Kim J.Y.; Yi H.K.; Park I.S.; Cho N.P.; Cho S.D.; Growth-suppressive effect of suberoylanilide hydroxamic acid (SAHA) on human oral cancer cells. Cell Oncol (Dordr) 2016,39(1),79-87","journal-title":"Cell Oncol (Dordr)"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"S576","DOI":"10.4103\/0973-1482.177220","volume":"14","author":"Jang B.","year":"2018","unstructured":"Jang B.; Kim L.H.; Lee S.Y.; Lee K.E.; Shin J.A.; Cho S.D.; Trichostatin A induces apoptosis in oral squamous cell carcinoma cell lines independent of hyperacetylation of histones. J Cancer Res Ther 2018,14(Suppl.),S576-S582","journal-title":"J Cancer Res Ther"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"87","DOI":"10.2217\/epi.12.68","volume":"5","author":"Sarkar S.","year":"2013","unstructured":"Sarkar S.; Goldgar S.; Byler S.; Rosenthal S.; Heerboth S.; Demethylation and re-expression of epigenetically silenced tumor suppressor genes: sensitization of cancer cells by combination therapy. Epigenomics 2013,5(1),87-94","journal-title":"Epigenomics"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3892\/ijmm.2016.2597","volume":"38","author":"Ma J.","year":"2016","unstructured":"Ma J.; Zhang Y.; Wang J.; Zhao T.; Ji P.; Song J.; Zhang H.; Luo W.; Proliferative effects of gamma-amino butyric acid on oral squamous cell carcinoma cells are associated with mitogen-activated protein kinase signaling pathways. Int J Mol Med 2016,38(1),305-311","journal-title":"Int J Mol Med"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3892\/ijo.22.6.1201","volume":"22","author":"Yakushiji T.","year":"2003","unstructured":"Yakushiji T.; Uzawa K.; Shibahara T.; Noma H.; Tanzawa H.; Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. Int J Oncol 2003,22(6),1201-1207","journal-title":"Int J Oncol"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1158\/1940-6207.CAPR-16-0180","volume":"10","author":"Mallery S.R.","year":"2017","unstructured":"Mallery S.R.; Wang D.; Santiago B.; Pei P.; Schwendeman S.P.; Nieto K.; Spinney R.; Tong M.; Koutras G.; Han B.; Holpuch A.; Lang J.; Benefits of multifaceted chemopreventives in the suppression of the oral squamous cell carcinoma (OSCC) tumorigenic phenotype. Cancer Prev Res (Phila) 2017,10(1),76-88","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref=85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0215234","volume":"14","author":"Osei-Sarfo K.","year":"2019","unstructured":"Osei-Sarfo K.; Gudas L.J.; Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells. PLoS One 2019,14(4)","journal-title":"PLoS One"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1600-0765.2011.01392.x","volume":"46","author":"Cantley M.D.","year":"2011","unstructured":"Cantley M.D.; Bartold P.M.; Marino V.; Fairlie D.P.; Le G.T.; Lucke A.J.; Haynes D.R.; Histone deacetylase inhibitors and periodontal bone loss. J Periodontal Res 2011,46(6),697-703","journal-title":"J Periodontal Res"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/jcb.29137","volume":"121","author":"Algate K.","year":"2020","unstructured":"Algate K.; Haynes D.; Fitzsimmons T.; Romeo O.; Wagner F.; Holson E.; Reid R.; Fairlie D.; Bartold P.; Cantley M.; Histone deacetylases 1 and 2 inhibition suppresses cytokine production and osteoclast bone resorption in vitro. J Cell Biochem 2020,121(1),244-258","journal-title":"J Cell Biochem"},{"key":"ref=88","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19124071","author":"Chang M.C.","unstructured":"Chang M.C.; Chen Y.J.; Lian Y.C.; Chang B.E.; Huang C.C.; Huang W.L.; Pan Y.H.; Jeng J.H.; Butyrate stimulates histone H3 acetylation, 8-isoprostane production, rankl expression, and regulated osteoprotegerin expression\/ secretion in MG-63 osteoblastic cells. Int J Mol Sci, 2018, 19(12), 4071","journal-title":"Int J Mol Sci, 2018, 19(12), 4071"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666200114114802","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/178297\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867327666200114114802","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T18:30:48Z","timestamp":1660069848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/178297\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":88,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867327666200114114802","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2019-09-06","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-12","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-11-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-04-02","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}